Global Opioid Receptor Agonist Market - Industry Trends and Forecast to 2029

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

Global Opioid Receptor Agonist Market - Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

>Global Opioid Receptor Agonist Market, By Drugs (Fentanyl, Codeine, Morphine, Buprenorphine, Others), Receptor Binding (Full Agonist, Partial Agonist), Indication (Pain management, Cough Suppression, Diarrhoea suppression, others), Route of Administration (Intravenous, Subcutaneous, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)-Industry Trends and Forecast to 2029.

Opioid Receptor Agonist Market

Opioid Receptor Agonist Market Analysis and Insights

Opioids are a type of painkiller that works by acting on the neurological system. They're mostly utilized for anaesthetic and pain relief. An agonist is a pharmacological molecule that activates specific brain receptors. When only a small number of receptors are engaged, this agonist elicits a strong physiological/pharmacological response, indicating that the medication has high intrinsic activity. Fentanyl, morphine, dihydromorphinone, meperidine, oxycodone, and oxymorphone are all strong agonist opioids. Opioid receptors are G-protein-coupled inhibitors that are primarily found in peripheral tissues and interfere with opioid receptors' pain-signaling function. Agonists are pain relievers that function by binding opioid receptors and reducing pain experience.

  • The rise in the aviation sector is escalating the growth of opioid receptor agonist market. Data Bridge Market Research analyses that the opioid receptor agonist market will grow at a CAGR of 4.50% during the forecast period of 2022 to 2029.

Opioid Receptor Agonist Market Dynamics

Drivers

Major factors that are expected to boost the growth of the opioid receptor agonist market in the forecast period are as follows

  • The rise in the incidence of chronic pain in adults

The number of people suffering with chronic pains is increasing rapidly. This is anticipated to drive the growth of global opioid receptor agonist market.

  • The growing cases of orthopedic diseases

Rise in the number of cases of joint replacement surgeries, such as total knee and hip replacement, is one of the major contributors to market growth.

Growing of the elderly population which leads to complications such as orthopedic surgeries and rise in the prevalence of chronic pain are lifting the growth of the opioid receptor agonist market.

Opportunities

In addition, the growing attention on the abuse-deterrent formulation (ADF) by generic manufacturers will further provide potential opportunities for the growth of the opioid receptor agonist market in the coming years.

Restraints/Challenges

On the other hand, the initiation of generics version of branded drugs is further projected to impede the growth of the opioid receptor agonist market in the near future.

This opioid receptor agonist market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on opioid receptor agonist market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

The opioid receptor agonist market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Covid-19 Impact on Opioid Receptor Agonist Market

The COVID-19 pandemic and the lockdown scenario in several countries worldwide have impacted the financial status of businesses across all sectors, counting the private healthcare sector. The entire supply chain of the healthcare industry has been impacted due to strict lockdown in several regions. Thus, impact of the Coronavirus has limited the growth of the opioid receptor agonist market due to decline in supply of raw materials and pharmaceutical drugs of manufacturing companies globally associated with opioids.

Recent Development

  • In September 2020, Fujian Cancer Hospital introduced a phase III clinical trial to evaluate the efficiency and well-being of fentanyl patch patients with moderate cancer pain in opioid-naive patients.
  • In March 2020, Trevena Inc. received the U.S. Food and Drug Administration (FDA) approval for OLINVYK (oliceridine). It is an opioid agonist indicated in adults so as to manage acute pain.

Global Opioid Receptor Agonist Market Scope

The opioid receptor agonist market is segmented on the basis of drugs, receptor binding, indication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

  • Fentanyl
  • Codeine
  • Morphine
  • Buprenorphine
  • Others

On the basis of drugs, the opioid receptor agonist market is segmented into fentanyl, codeine, morphine, buprenorphine and others.

Receptor Binding

  • Full Agonist
  • Partial Agonist

On the basis of receptor binding, the opioid receptor agonist market is segmented into full agonist, partial agonist.

Indication

  • Pain management
  • Cough Suppression
  • Diarrhoea suppression
  • others

On the basis of indication, the opioid receptor agonist market is segmented into pain management, cough suppression, diarrhea suppression and others.

Route of Administration

  • Intravenous
  • Subcutaneous
  • Others

On the basis of route of administration, the opioid receptor agonist market is segmented into oral, parenteral and others.

End Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

On the basis of end users, the opioid receptor agonist market is segmented into hospitals, homecare, specialty clinics and others.

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

On the basis of distribution channel, the opioid receptor agonist market is segmented into hospital pharmacy, online pharmacy and retail pharmacy.

Opioid Receptor Agonist Market Regional Analysis/Insights

The opioid receptor agonist market is analysed and market size insights and trends are provided by country, drugs, receptor binding, indication, route of administration, end users and distribution channel as referenced above.

The countries covered in the opioid receptor agonist market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the opioid receptor agonist market due to the rise in the incidence of rate of cancer. Furthermore, the occurrence of major key players will further boost the growth of the opioid receptor agonist market in the region during the forecast period.

Asia-Pacific is projected to observe significant amount of growth in the opioid receptor agonist market due to the suitable reimbursement schemes. Moreover, the growing of worldwide vendors is further anticipated to propel the growth of the opioid receptor agonist market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Opioid Receptor Agonist Market Share Analysis

The opioid receptor agonist market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to opioid receptor agonist market.

Some of the major players operating in the opioid receptor agonist market are Teva Pharmaceutical Industries Ltd, Johnson & Johnson Services, Inc, Pfizer Inc, Fresenius Kabi AG, Mylan N.V., Allergan, US WorldMeds, LLC, Piramal Critical Care, DAIICHI SANKYO COMPANY, LIMITED, Purdue Pharma L.P., Hikma Pharmaceuticals PLC, Endo Pharmaceuticals Inc,  Sun Pharmaceutical Industries Ltd, Tris Pharma, Inc and Indivior PLC among others.


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Testimonial